Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study

Authors:

Abstract
Objectives. To evaluate the long-term efficacy and safety of infliximab in patients with Behçet's disease (BD) and refractory bilateral posterior uveitis, and to assess the proportion of relapse-free subjects through months 12 and 24.